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Quality of transition to end-of-life care 
for cancer patients in the intensive care unit
Sophie J Miller1†, Nishita Desai2†, Natalie Pattison2, Joanne M Droney1, Angela King3, Paul Farquhar‑Smith2 
and Pascale C Gruber2*
Abstract 
Background: There have been few studies that have evaluated the quality of end‑of‑life care (EOLC) for cancer 
patients in the ICU. The aim of this study was to explore the quality of transition to EOLC for cancer patients in ICU.
Methods: The study was undertaken on medical patients admitted to a specialist cancer hospital ICU over 6 months. 
Quantitative and qualitative methods were used to explore quality of transition to EOLC using documentary evidence. 
Clinical parameters on ICU admission were reviewed to determine if they could be used to identify patients who were 
likely to transition to EOLC during their ICU stay.
Results: Of 85 patients, 44.7% transitioned to EOLC during their ICU stay. Qualitative and quantitative analysis of the 
patients’ records demonstrated that there was collaborative decision‑making between teams, patients and families 
during transition to EOLC. However, 51.4 and 40.5% of patients were too unwell to discuss transition to EOLC and 
DNACPR respectively. In the EOLC cohort, 76.3% died in ICU, but preferred place of death known in only 10%. Age, 
APACHE II score, and organ support, but not cancer diagnosis, were identified as associated with transition to EOLC 
(p = 0.017, p < 0.0001 and p = 0.001).
Conclusions: Advanced EOLC planning in patients with progressive disease prior to acute deterioration is warranted 
to enable patients’ wishes to be fulfilled and ceiling of treatments agreed. Better documentation and development of 
validated tools to measure the quality EOLC transition on the ICU are needed.
Keywords: Palliative, Intensive care, Communication, Do not resuscitate
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Background
Outcomes for critically ill cancer patients have improved 
over the last decade, and intensivists are increasingly will-
ing to initiate a ‘trial of intensive care unit (ICU) therapy’ 
in patients with advanced cancer [1, 2]. The aim of a trial 
of intensive care therapy is to support patients’ recov-
ery, treat reversible causes of illness and help patients 
survive immediate threats to their lives. It is estimated 
that 18–30% of cancer patients use of intensive care 
services [3, 4]. Advances in cancer diagnosis, treatment 
and general ICU care have led to better outcomes in 
patients with cancer admitted to the ICU [1, 2]. However, 
morbidity and mortality still remains high, with cancer 
patients admitted to ICU having a mortality of 27–43% 
[5–7]. Recent studies have shown similar ICU mortality 
rates for patients with solid tumours and haematological 
malignancies [2, 8, 9].
The transition from intensive care with the goal to save 
or prolong life to end-of-life care (EOLC) can often be a 
difficult decision to make for clinicians, patients and fam-
ilies [10]. Clinical parameters to help clinicians identify 
patients who are likely to transition to EOLC during their 
ICU stay are often not easily defined [9, 11]. The ability to 
identify clinical parameters early in their ICU admission 
that could help predict likelihood of transition to EOLC 
could improve the quality of care for cancer patients.
Previous studies have demonstrated that care pathways 
and communication during transition to EOLC for criti-
cally ill patients and their families in the ICU setting is 
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not always optimal [12–15]. Problems reported have been 
poor communication; discordance about treatment plans 
and goals; high prevalence of pain and distressing symp-
toms [16–19]. Healthcare providers also highlight a lack 
of knowledge and training in EOLC [20]. Furthermore, it 
is unclear which, if any, palliative measures are effective, 
or increase satisfaction, in the ICU [21]. Clarke et al. and 
a subsequent consensus statement from the American 
College of Critical Care Medicine recommended seven 
quality indicators (Table  1) for improving the EOLC of 
ICU patients during the dying process [15, 22].
The primary aim of this study was to explore the qual-
ity of transition to EOLC for medical patients with can-
cer who died, or transitioned to end-of-life on the ICU. 
Medical patients only were sampled, as the predicted 
and actual mortality for surgical patients in the unit was 
historically very low, and few transitioned to end-of-life 
[2]. The literature attests to the high mortality in medical 
ICU cancer patients, and low surgical mortality [24, 25]. 
The secondary aim was to identify parameters on ICU 
admission that could help determine patients who were 
likely to transition to EOLC during their ICU stay.
Methods
Setting
This study was approved by the local Committee for 
Clinical Research. The study took place on the ICU in 
a 269-bedded specialist adult cancer hospital located 
across two sites in London. The hospital serves the 
local population and is also a tertiary referral centre for 
patients with cancer from across the United Kingdom 
and abroad. The 16-bedded mixed medical and surgical 
ICU admits approximately 1,400 patients per year and 
has capacity for both level 2 (single organ support, or 
extensively post-operative care) and 3 (two or more organ 
support, or advanced respiratory support) care [26]. All 
referrals and admissions to ICU are discussed with the 
ICU consultant. No formal EOLC protocol was in place 
in the ICU during the study period following the aboli-
tion of the Liverpool Care Pathway [27]. However, several 
of the recommendations for improving communication 
at the end-of-life by the American College of Critical 
Care Medicine had been adopted in the unit [15]. These 
included formal communication skills training of ICU 
and Palliative Care Consultants, interdisciplinary team 
rounds, palliative care team input at weekly ICU multi-
disciplinary team meetings and regular family meetings.
All medical patients with cancer admitted to the ICU 
over a 6-month period from 01.03.2013 to 01.08.2013 
were included in this study. Patients <16  years, without 
a cancer diagnosis, or who had undergone elective or 
emergency surgery were excluded as the focus on this 
study was primarily on medical cancer patients. For 
those patients who had more than one admission dur-
ing the study period, only the patient’s last admission was 
included in the analysis. Sepsis was defined according to 
the Surviving Sepsis Guidelines [28].
Study design
A retrospective review of patient records was carried out to 
explore patients’ demographics and co-morbidities; cancer 
type and stage; reason for hospital and ICU admission; doc-
umented communication between teams, patients and rel-
atives (detailed from care records, team meetings and daily 
Table 1 American College of  Critical Care Medicine key recommendations for  improving the care of  ICU patients dur-
ing the dying process: adapted from Clarke et al. [22] and Mularski et al. [23]
1. Patient‑ and family‑centred decision‑making
 Involve patient and family in decision‑making/discussions as appropriate to the individual; initiate advanced care planning
2. Communication with team/patient/family
 Meet with the multidisciplinary team to plan care; meet regularly with patient and family to review situation and answer questions; sensitive com‑
munication
3. Spiritual support
 Regularly assess and document spiritual needs; document offer of spiritual support
4. Emotional and practical support
 Open visitation for family; provide support and written logistical information (e.g. accommodation); financial and bereavement advice
5. Symptom management and comfort care
 Assess symptoms before and after interventions; follow best clinical practice using pharmacologic and non‑pharmacologic means for best symptom 
management
6. Continuity of care
 Maximise continuity of care for patients; introduce new clinicians
7. Emotional and organisational support for intensive care unit clinicians
 Support and educate staff on the ICU who are caring for dying patients
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ward round annotations in the electronic patient records); 
documented palliative care team involvement; documented 
evidence of resuscitation and ceiling of care decisions; doc-
umented quality of EOLC provision, and ICU mortality.
To determine the care process and quality of EOLC tran-
sitions on the ICU, quality indicators recommended by 
American College of Critical Care Medicine were used in 
the qualitative documentary analysis (Table  1) [15]. The 
quantitative variables were categorised into process and 
outcome domains. The first five points (Domains 1–5) 
were used in the analysis on processes of EOL transition 
and provision of EOLC in our ICU. Communication not 
only included documented presence of patient, family and 
team members, but also in some cases, a qualitative analy-
sis of the documented discussion. At the time of this study, 
standardised symptom assessment tools were not routinely 
used or integrated into the electronic documentation. 
Symptom control (Domain 5) was defined, for simplic-
ity, as documented evidence of pharmacological and non-
pharmacological control of symptoms such as pain, nausea, 
vomiting, diarrhoea, and anxiety. Assessments were made 
prior and after intervention to determine if patients’ had 
achieved adequate symptom control. Domains 6 and 7 
were excluded as they relate to organisational processes 
that could not be determined through patient records 
review. Palliative or non-curative treatment intent was 
defined as patients with no further active treatment options 
available, but those that could be on phase 1 trials or be 
receiving treatment to control or maintain disease stability 
but without curative intent. In contrast, curative intent was 
defined as patients who were receiving active treatment for 
their cancer with an intention of cure [29].
Patient records were examined using the Electronic 
Patient Record (EPR), IntelliView Clinical Information Port-
folio (ICIP), chaplaincy database, and written notes. All data 
was double checked for accuracy by two investigators. All 
data were entered onto an excel database and collated into 
46 variables under the aforementioned process and out-
come categories. These variables were then categorised and 
tabulated into the five domains (Domains 1–5). Data were 
pseudo-anonymised, and dealt with Good Clinical Practice 
guidelines and United Kingdom Data Protection Act.
Identification of cohorts: ‘EOLC’ vs ‘full active ICU care’
Following data collection, patients were divided into two 
cohorts: patients who received full active management 
with organ support throughout their ICU stay and whose 
main focus of care remained prolongation of survival 
with curative intent (‘full active ICU care’ cohort); and 
those patients who had transitioned from full active man-
agement to EOLC during their ICU stay or died on the 
ICU (‘EOLC’ cohort) (Fig. 1). The transition to EOLC was 
Fig. 1 Flowchart of protocol for patient selection and analysis.
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ascertained on an individual patient basis and decisions 
were made when the teams (parent medical team, ICU 
team and sometimes the palliative care team) jointly con-
cluded that continuation of life-prolonging organ support 
would be futile and not in the patients’ best interests. 
Families (and patients, if they had capacity) were involved 
in these discussions. It is recognised however, that some 
of EOLC cohort may have received life-prolonging organ 
support during the early part of their ICU stay before 
transitioning to EOL care. Equally, symptom control was 
given in the full active care cohort where needed.
Data analysis
Quantitative data were analysed using SPSS statistics 
software (version 20, Chicago, IL, USA). Comparison was 
made between the two cohorts using standard descriptive 
statistics. For categorical variables such as organ support 
required in ICU and performance status, Fisher’s exact 
test and Chi squared tests were performed to compare 
data between the two groups. Continuous data was ana-
lysed using the Mann–Whitney U (for non-parametric 
data including age) and student t test for parametric data. 
A statistical significance p < 0.05 was used when compar-
ing the two cohorts.
Multiple logistic regression was used to investigate the 
joint effect of clinical variables on the whether or not 
patients transitioned to the EOLC cohort or not. Fac-
tors with p < 0.1 on univariate analysis were included in 
the multivariate modelling. Variables with p  >  0.1 were 
excluded in order to reduce the number of predictor vari-
ables. Variable selection was carried out using a stepwise 
method, with p < 0.05 and p > 0.1 as criteria for entry and 
removal, respectively. Only factors with p  <  0.05 were 
retained in the final model.
Data from the EOLC cohort were further analysed 
using descriptive statistics to explore the quality of EOLC 
being delivered on the ICU.
Text data from all medical records (ICIP and hospital 
EPR) was analysed using qualitative thematic analysis. 
Undertaking textual analysis enriched the quantitative 
data yielded [30, 31]. A mixed analysis allowed examina-
tion and exploration of unusual quantitative findings [32]. 
Thematic analysis provided a structure for identifying 
patterns in data and involved steps of data codification; 
testing and connecting codes, searching and establishing 
themes; reviewing and corroborating themes.
Results
There were 3,203 hospital in-patient admissions dur-
ing the study period, and of these 669 were admitted it 
the ICU (20.9%). Of the ICU admissions, 85 were medi-
cal patients (12.2%), all of whom were included in the 
analysis.
Quantitative analysis comparing ‘Full active ICU care’ 
with ‘EOLC’ cohorts
Of the 85 patients analysed, 38 patients (44.7%) met the 
criteria for ‘EOLC’ and 47 patients (55.3%) remained 
for ‘full active ICU care’. Patient demographics are out-
lined in Table 2. Median age and APACHE II score was 
higher in the EOLC group compared to the full active 
ICU care group (66.5 vs. 59 years, p = 0.017) and (21 vs. 
16, p < 0.0001), respectively. The EOLC cohort required a 
higher level of organ support (intubation 44.7 vs. 12.8%, 
p  =  0.001; vasopressors 55.3 vs. 27.7%, p  =  0.014 and 
RRT 28.9 vs. 8.5%, p  =  0.021). There was no statistical 
difference in cancer type, disease stage or co-morbidities. 
On multivariate analysis, APACHE II score, the need for 
intubation and non-invasive ventilation remained signifi-
cantly associated with a poor prognosis (Table 3).
Overall ICU mortality was 34% for all medical patients 
admitted to the ICU and 3.7% (118/3,203 patients) for all 
hospital in-patients during the study period.
Quantitative analysis of the quality of transition to EOL
Of the 38 patients who were included in the EOLC 
cohort, only one patient was admitted for symptom con-
trol alone. All other patients were initially admitted for 
full active ICU management.
Most patients in the EOLC cohort (37/38 patients; 
97.4%) had clear documented evidence of transition from 
full active care to EOLC.
ICU and in‑hospital mortality
Most patients (29/38 patients; 76.3%) in the EOLC cohort 
died on the ICU. Of the remaining 9 patients, 7 died on the 
ward; one died in hospice and one was transferred to their 
home country whilst remaining intubated. In-hospital 
mortality for the EOLC cohort was (36/38 patients; 94.7%).
Resuscitation decisions
On admission to ICU most patients in the EOLC cohort 
(34/38 patients; 89.5%) were for full resuscitation. In the 
EOLC cohort ‘do not attempt cardiopulmonary resuscita-
tion’ (DNACPR) orders were completed for 47% patients 
within 48 h of ICU admission. Most patients (97.4%) in 
the EOLC cohort had documented evidence of DNACPR 
at some point during their ICU stay. Sixty-nine percent 
of patients died within 3 days of DNACPR decision. The 
time from DNACPR decision to death was a median of 
1.5 days (range 0–93 days). In contrast, amongst the ‘full 
active ICU care’ cohort, just 2/45 patients (4.4%), had a 
DNACPR order documented during their ICU stay.
Documented quality markers for transition to EOLC
The quality of EOLC delivered during transition to end-
of-life care was assessed using the domains adapted from 
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the American College of Critical Care Medicine Consen-
sus statement, is shown in Table 4 [15, 22, 23].
Qualitative thematic analysis
Data were analysed qualitatively for all patients under a 
priori framework analysis categories of prognostication, 
decision-making and EOLC based on the quantitative 
findings. These were modified according to the 19 sub-
themes (Fig. 2) and resulted in five main themes (Table 5).
When initiating end-of-life transitions, where patients 
had capacity, decisions were made collaboratively with 
families and teams. When supportive care was deemed 
appropriate, rather than focusing on active treatment, 
palliative care input was quickly sought. The excerpt (1.1) 
exemplifies consensus building as well as highlighting the 
consensus between teams in the next theme.
Parent medical and critical care team decision-mak-
ing referred to how critical care teams sought early joint 
Table 2 Comparison of characteristics between the ‘Full active ICU care’ cohort and the ‘EOLC’ cohort
Statistically significant variables are in italics
* 3 patients in ‘full active ICU care’ cohort and 4 patients in ‘EOLC’ cohort had leukaemia and therefore were excluded from this analysis.
** Some patients had more than one reason for admission hence total numbers greater than 100% per cohort.
Characteristic Full active ICU care n = 47 EOLC n = 38 P value
Age, median (range) in years 59 (19–88) 66.5 (28–81) 0.017
Gender, n (%) M 21 (44.7%) M 19 (50.0%) 0.62
F 26 (55.3%) F 19 (50.0%)
APACHE II score median (range) 16 (5–31) 21 (10–47) <0.0001
Type of cancer, n (%)
 Solid tumour 35 (74.5%) 24 (63.2%) 0.26
 Haematological tumour 12 (25.5%) 14 (36.8%) 0.26
Stage of disease, n (%)*
 No known spread 7 (14.9%) 6 (15.8%) 0.92
 Local spread (spread to neighbouring tissues) 7 (14.9%) 2 (5.3%) 0.14
 Nodal spread (spread to lymph nodes) 7 (14.9%) 5 (13.2%) 0.82
 Distant metastases 23 (48.9%) 21 (55.3%) 0.47
Cancer treatment, n (%)
 Chemotherapy 32 (68%) 29 (76.3%) 0.4
 Radiotherapy 11 (23.4%) 4 (10.5) 0.16
 Palliative treatment (definitions in text) 19 (43.1%) 17 (44.7%) 0.69
 Curative treatment (definitions in text) 22 (46.8%) 16 (42.1%) 0.66
 No treatment 6 (12.8%) 3 (7.9%) 0.51
Reason for ICU admission, n (%)**
 Respiratory failure 19 (40.4%) 17 (44.7%) 0.69
 Renal failure 10 (21.3%) 9 (23.7%) 0.79
 Cardiac 7 (14.9%) 3 (7.9%) 0.5
 Sepsis 11 (23.4%) 12 (31.6%) 0.4
 Neurology 2 (4.3%) 1 (2.6%) 0.69
 Other 8 (17.0%) 7 (18.4%) 0.73
Time of referral to ICU, n (%)
 Out of hours 22 (46.8%) 16 (42.1%) 0.82
 Weekend 11 (23.4%) 6 (15.8%) 0.55
Organ support required during ICU stay, n (%)
 Invasive ventilation 6 (12.8%) 17 (44.7%) 0.001
 Vasopressors 13 (27.7%) 21 (55.3%) 0.014
 Renal replacement therapy (RRT) 4 (8.5%) 11 (28.9%) 0.021
 Non‑invasive ventilation (NIV) 9 (19.1%) 12 (31.6%) 0.19
Baseline performance status documented, n (%) 18 (38.3%) 16 (45.7%) 0.72
Need for symptom control in ICU, n (%) 27 (57.0%) 27 (71.0%) 0.19
Seen by palliative care in ICU, n (%) 7 (19.1%) 20 (52.6%) 0.001
Cancer prognosis documented prior to ICU, n (%) 10 (21.2%) 4 (10.5%) 0.15
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decision-making with parent medical teams when there 
was doubt over the possibility of critical illness recovery 
(theme 3). This planning meant that some patients were 
transferred out of the unit and received EOLC on the ward.
Poor critical illness related outcomes and cancer prog-
nosis made it straightforward to reach consensus and 
rationalise decisions. Prognosis was communicated 
where possible (2.1) and where there was uncertainty 
regarding outcome from the critical illness perspective, it 
was more likely that patients died with full intensive care 
treatments in situ (2.2, 2.3).
Furthermore, teams negotiated to try critical care treat-
ment for a period of time, allowing opportunity for anti-
cancer treatments to work, and allowing for a trial of ICU 
to reverse acute problems. If families were reluctant for 
EOLC transitions and wished for full active treatment to 
continue, the intensivists would often continue with the 
caveat that if there was no improvement in a specified 
time, they would initiate a transition to end-of-life (2.1).
If families (and patients, when able) were receptive to 
EOLC transition, then the critical care team acted swiftly to 
focus on EOLC, either placing a ceiling of care (limitation 
of treatment) (5.2), or withdrawing treatment (5.1, 5.3).
Integrative palliative care referred to how palliative 
care input was sought on the majority of patients who 
actually died in critical care, despite the short time to 
death from withdrawal or limitation of treatment (theme 
4). This facilitated the focus on comfort measures, and 
away from high-intensity treatment at end-of-life, but 
depended on timely referral. Some intensivists advocated 
an integrative approach where palliative care became 
involved early, to assist in advanced care planning.
Discussion
In this study we found that APACHE II scores, age and 
levels organ support were found to be associated with 
patients who were likely to transition from full ICU active 
care to EOLC. These parameters have also been found to 
correlate with poor outcomes in other studies [2, 8, 33]. 
Cancer stage or diagnosis was not associated with transi-
tion to EOLC in keeping with findings from other studies 
[2, 9]. On multivariate analysis, APACHE II score, the 
need for intubation and non-invasive ventilation were 
significantly associated with transition to EOLC.
Our results indicate that teams and relatives com-
municated frequently during the period of transition to 
EOLC. These findings were supported by the qualitative 
analysis, which illustrated that families understood the 
appropriateness of transitions to EOLC, and were keen 
to avoid suffering when reversal of the underlying con-
dition was not possible. Despite some qualitative docu-
mented cases of good communication with families, 
patients were often too unwell to engage in conversa-
tions around transition to EOLC and/or DNACPR once 
in ICU. Even in this group of patients with known can-
cer, few patients in the EOLC cohort had been asked and 
had documented evidence of a preferred place of death. 
Despite the recent initiatives and published reports that 
patients want to be involved in decision-making, use of 
advanced care planning and discussions about EOLC 
with patients and their families remains infrequent [34–
36]. Research indicates that most people want to die at 
home [37, 38]. However, the majority of our patients in 
the EOLC cohort died in hospital, with over three-quar-
ters of patients in the EOLC cohort dying in the ICU. 
For patients with advanced disease it is important that 
discussions and documentation about ceilings of treat-
ment, prognosis and patient wishes, are done early in 
the disease course when patients are still well enough 
to engage, rather than in the ICU. Even in our institu-
tion, where the palliative care team forms an integral 
part of the service this issue remains challenging. In this 
study the number of patients in the EOLC cohort that 
we able to participate in discussions about their can-
cer prognosis (43.2%), DNACPR decision (40.5%) and 
preferred place of death (10.5%) during their ICU stay 
was low. Whilst this may just represent of the number 
of patients who presented with acute, unforeseen dete-
rioration in their clinical condition unrelated to their 
cancer progression, it highlights the need for early pal-
liative care involvement and advanced EOLC planning. 
There may be frequent opportunities for discussion dur-
ing outpatient visits and in-patient admissions. A recent 
study indicated that patients having palliative chemo-
therapy towards the end-of-life are more likely to die in 
ICU [39]. When the focus of care is on survival, health 
professionals are often reluctant to discuss prognosis or 
plans in the event of deterioration as it may be consid-
ered unnecessarily distressing to patients [40]. Yet, for 
some patients, earlier discussion of prognosis, treatment 
options and EOLC wishes may mean they are better 
informed to make decisions about their care. Also, Rees 
et al. [41] did not find that these discussions caused dis-
tress for most of their patients.
Table 3 Multivariate analysis of  factors associated 
with transition to EOLC
Multivariate logistic regression model of factors associated 
with patients transitioning to EOLC in ICU
Variable P value OR (95% CI)
APACHE II score 0.003 1.144 (1.046–1.251)
Invasive ventilation 0.012 0.206 (0.06–0.703)
Non‑invasive ventilation 0.027 0.269 (0.084–0.863)
Constant 0.545 0.500
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Often the decision to make a patient DNACPR or to 
transition to EOLC was made within 48 h of ICU admis-
sion, following a ‘trial of ICU’. Tools have been developed 
for use in patients admitted to ICU to improve commu-
nication and palliative care [42]. These tools require fur-
ther validation and review but may be used to support 
medical decision-making and prompt early discussions 
between clinicians, patients and their families about 
patients’ wishes, potential therapeutic options and antici-
pated outcomes.
Few patients (10%) who transitioned to EOLC dur-
ing their ICU stay were already known to the palliative 
care team prior to ICU admission. This may be due to 
the fact that many patients were treated with curative 
intent, and had not required palliative care interven-
tion prior to their critical illness. Our qualitative data 
Table 4 Quality markers for EOLC on the ICU
DNACPR do not attempt cardiopulmonary resuscitation.
* Symptom control by interventions delivered by any medical team, not just specialist palliative care team.
** Often referred for more than one reason.
Quality markers for end‑of‑life care on the intensive care unit % (N/total N)
Symptom management and comfort care
 Documented evidence of need for symptom control as evidenced by the documented evidence of symptoms such as pain, shortness 
of breath, anxiety, nausea, vomiting, constipation
71 (27/38)
 Documented evidence of successful symptom control (N = 27)* 79 (21/27)
 Documented evidence that the patient was reviewed by the hospital specialist palliative care team 53(20/38)
 Reason for referral to hospital specialist palliative care team (N = 20)**
  Symptom control 80 (16/20)
  EOLC 80 (16/20)
  Psychosocial support 25 (5/20)
Communication with team, patient and family
 Documented evidence that a professional decision had been made that life and organ support was no longer feasible or appropriate 
and that these therapies were going to be withdrawn or withheld and that the likelihood of death was high
44 (37)
 Is there documented evidence that this decision had been discussed with the patient, relative and oncology team
  Discussed with patient 43 (16/37)
  Not possible to discuss with patient being too unwell 51 (19/37)
  No record of whether or not discussed with patient 5 (2/37)
  Discussed with relative 97 (36/37)
  Discussed with parent oncology team 92 (34/37)
 Documented evidence that a professional decision had been made that the patient should not be for cardiopulmonary resuscitation in 
the event of a cardiopulmonary arrest (DNACPR order completed)
44 (37)
 Documented evidence that this decision was:
  Discussed with patient 41 (15/37)
  Not possible to discuss with patient as too unwell 41 (15/37)
  No record of whether or not discussed with patient 19 (7/37)
  Discussed with relative 89 (33/37)
  Discussed with parent oncology team 73 (27/37)
Patient‑ and family‑centred decision‑making
 Documented evidence that the patient had an advance directive or an Advanced Decision to Refuse Treatment in place 0 (0/38)
 Documented evidence about the patient’s wishes and preferences for their preferred place of death 11 (4/38)
Emotional and practical support
 Documented evidence that psychological support was offered to the patient 29 (11/38)
 Documented evidence that psychological support was offered to relatives 21 (8/38)
 Documented evidence that practical and welfare advice (e.g. about welfare benefits/accommodation) was offered to the patient/rela‑
tives
21 (8/38)
Spiritual support
 Documented evidence that a discussion took place with the patient or family regarding their spiritual needs or that chaplaincy support 
was offered
37 (14/38)
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suggests that intensivists had the skills to manage 
symptoms and support families. Even when the patient 
was admitted to the ICU, the palliative care team were 
only involved in 53% of patients in the EOLC cohort. 
Early palliative care involvement has been associated 
with a lower proportion of deaths occurring in the ICU 
[43].
Based on clinical documentation, spiritual, psychologi-
cal and welfare support was offered to patients/families 
at end-of-life in only a third of cases. It may have been 
that support was offered and declined, that the ICU team 
was already giving adequate support to patients and their 
families, or that these needs were not consistently con-
sidered. Family satisfaction with EOLC decision-making 
has been closely associated with documented discussion 
of patient wishes and spiritual needs [44]. In the United 
Kingdom, one of the useful aspects of the Liverpool Care 
Pathway (LCP) was that it acted as a prompt for staff to 
consider emotional, spiritual and psychological support 
at the end-of-life [27, 45]. In the post-Liverpool Care 
Pathway era, we need to ensure these vital quality indica-
tors of good EOLC are considered, offered if appropriate 
and clearly documented. There are local and national ini-
tiatives underway to develop such tools [46].
One of the limitations of this study was that the data 
were collected retrospectively therefore the results not 
only reflect the processes of care, but also were reliant 
on the quality of documentation. For example, only spe-
cific aspects of the documented content of communica-
tion were evaluated and the quality of communication 
could not always be ascertained from the documented 
data. Also, the binary assessment of some of the quality 
markers may have been, in some circumstances, insuf-
ficient to assess quality of the care process provided but 
in some cases could be further explored in the qualita-
tive analysis. It could be also argued that the findings 
are limited to the results of a single, tertiary centre; 
however, the authors believe that the findings may have 
wider applicability, as the themes identified are com-
mon to findings from other studies which have included 
general ICUs [14, 15]. The small sample size and pos-
sible existence of unmeasured confounding factors 
may have impacted on some of the conclusions drawn. 
Finally, only a limited assessment of end-of-life symp-
toms, and subsequent management, was undertaken; 
given the retrospective nature of the study. The use of 
defined assessment or outcome scales may have pro-
vided more robust information about the quality symp-
tom management.
Conclusions
Larger studies are required to identify and validate clini-
cal factors that may help identify patients with cancer 
who are likely to transition to EOLC during their ICU 
Fig. 2 Thematic structure of end‑of‑life care in Critical care.
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stay. Although qualitative and quantitative analysis of the 
records demonstrated that there was communication and 
collaborative decision-making between medical teams, 
patients and families during transition to EOLC, 40% 
of patients were too unwell to engage in conversations 
about preferences for care. This highlights the need for 
early advanced care planning, ideally prior to ICU admis-
sion. Our findings, although arguably those from a single 
centre, do have widely applicability, and demonstrate that 
there is a clear need for the development and validation 
of tools to support high-quality patient-centred EOLC in 
a critical care setting, across all domains.
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Table 5 Exploring the 5 main themes
1. Achieving a consensus to initiate end of life transitions
 1.1 ‘I have discussed his management with [oncologist] this morning. He agrees that it would not be appropriate to start [mechanical ventilation] [. . .] 
It is unlikely he will survive beyond the next few hours and even with full invasive ventilation it is unlikely he will survive beyond the next few days. 
We have therefore moved to palliation. [Wife] is in agreement that it would not be appropriate to intubate and ventilate him. (patient 79)
 1.2 ‘Prof [oncologist] reiterated our conversation we had with [patient] and [husband] this morning about the change from curative to palliative intent. 
Then we stressed the importance of symptom control, how we were going to involve the palliative care team, and how we would ensure reducing 
anxiety, distress and any discomfort…’ (patient 63)
 1.3 ‘[patient] agrees to intubation [. . .] but does not want CPR or any heroic measures to prolong her life.’ (patient 59)
 1.4 I talked with [oncologist] yesterday who is keen that we pursue every therapeutic option for [patient] at present and I discussed my reluctance to 
consider intubation for this gentleman because none of our intensive care treatments were improving his respiratory function [. . .] [Palliative care 
consultant] talked with the family and indeed I talked to [patient] yesterday who was adamant that he didn’t want further escalation. (patient 16)
2. Concomitant prognostication and managing uncertainty
 2.1 ‘Explained to [husband] that [patient] is gravely unwell at present, and that she may not survive this episode. We have explained to [husband] that 
we will do everything we can in CCU, and will have more of an idea within the next 24 to 48 hours of how her condition will progress. If she deterio‑
rates further, then we will do everything we can to keep her comfortable… (patient 81)’
 2.2 ‘Unable to wean off FiO2 [oxygen via oscillator mode on ventilator] and respiratory demands continue to increase. [patients]’ condition continued 
to deteriorate and discussions were had between the family, oncology and CCU team.’ (patient 83)
 2.3 Even were his GVHD to resolve imminently he would still be in multi‑organ failure[. . .] (patient 47)
3. Parent medical and critical care team decision-making
 3.1 ‘in view of limited cancer prognosis and, in event of requiring emergency sedation, intubation and ventilation that recovery to the point of accept‑
able quality of life would be unlikely’ (patient 40)
 3.2 ‘After discussion with [oncologist] and the family we decided not for further active management but continued high quality supportive care’ 
(patient 84)
4. Integrative palliative care
 4.1 ‘we stressed the importance of symptom control, how we were going to involve the palliative care team, and how we would ensure reducing anxi‑
ety, distress and any discomfort. (patient 17)
 4.2 ‘His continuing deterioration is indicative of end of life events and we discussed his management with the palliative care team (patient 15).
5. Family-centred versus patient-centred care
 5.1 ‘Consider discontinuation of NIV at an interval after son’s arrival on Monday. In the meantime—if [patient] wishes us to discontinue the NIV earlier, 
this would be appropriate—with sensitive communication to the family’ (patient 27)
 5.2 ‘They [family] understand that it is highly unlikely that Mrs D would be able to be weaned from invasive ventilation and agree as to the previous set 
ceiling of care of NIV [non‑invasive ventilation]. They understand she has developed multi‑organ failure and that our priority of care now would be 
solely her comfort.’ (patient 30)
 5.3 ‘Family did not want active treatment if no hope of recovery’ (patient 85)
 5.4 ‘Wife does not want us to try to communicate this to him now but would rather she did that herself if he became more alert later on.’ (patient 80)
 5.5 ‘We will leave her treatment as it as at present instead of withdrawal as her son is in transit from USA.’ (patient 30)
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